BioSpace News Archive

Drug Development

Medgenics, Inc. Acquires Phase II-Ready CNS Program: NFC-1

September 9, 2015
·
7 min read
Deals

EPIRUS Biopharmaceuticals Expands Biosimilar Pipeline And Capabilities Through Acquisition Of Bioceros

September 9, 2015
·
7 min read
Pharm Country

Pernix To Present At Morgan Stanley Global Healthcare Conference

September 9, 2015
·
1 min read
Drug Development

Vitae Pharma Announces Positive Top-Line Results From Initial Phase 1 Study Of First-In-Class Roryt Inhibitor VTP-43742 In Autoimmune Disorders

September 9, 2015
·
6 min read
Drug Development

Helsinn Group Release: Additional Data For anamorelin In ROMANA 1 And ROMANA 2 Studies Presented At 2015 International Association For The Study Of Lung Cancer (IASLC) World Conference On Lung Cancer (WCLC), In Denver

September 9, 2015
·
6 min read
Pharm Country

Egalet Announces Commercial Launch Of OXAYDO, The First And Only Immediate-Release Oxycodone Designed To Discourage Intranasal Abuse, And Launch Of IMPACT-Rx, A Patient Access Initiative

September 9, 2015
·
10 min read
Vestagen Technical Textiles, Inc. Release: Protective Apparel Innovator Vestagen Completes $3.3 Million Bridge Financing

September 9, 2015
·
3 min read
Drug Development

Asterias Biotherapeutics Announces Publication Of Preclinical Data That Supports The Safety And Use Of AST-OPC1 As A Treatment For Spinal Cord Injury (SCI)

September 9, 2015
·
4 min read
VolitionRX Demonstrates Nuq Blood Test Detects 81% Of Colorectal Cancers And 67% Of High Risk Adenomas In Large Double Blinded Clinical Trial

September 9, 2015
·
9 min read
Deals

Hill-Rom Completes Acquisition Of Welch Allyn

September 9, 2015
·
2 min read